Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Xetra  >  MorphoSys AG    MOR   DE0006632003

Delayed Quote. Delayed  - 06/24 05:35:04 pm
35.62 EUR   -5.19%
06/20 MORPHOSYS : Reports Publication of Clinical Case Report of a Blood C..
06/17 MORPHOSYS : Reports Publication of Clinical Case Report of a Blood C..
06/14 MORPHOSYS AG : Publication pursuant to §26 sect.1 WpHG (the German S..
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Xetra
06/20/2016 06/21/2016 06/22/2016 06/23/2016 06/24/2016 Date
39.395(c) 37.61(c) 38.04(c) 37.57(c) 35.62(c) Last
146 370 132 071 151 451 129 644 237 412 Volume
+3.85% -4.53% +1.14% -1.24% -5.19% Change
More quotes
Financials (€)
Sales 2016 49,6 M
EBIT 2016 -64,3 M
Net income 2016 -44,9 M
Finance 2016 219 M
Yield 2016 -
Sales 2017 65,4 M
EBIT 2017 -46,3 M
Net income 2017 -34,3 M
Finance 2017 199 M
Yield 2017 -
P/E ratio 2016 -
P/E ratio 2017
EV / Sales2016 14,6x
EV / Sales2017 11,4x
Capitalization 945 M
More Financials
Company
MorphoSys AG engages in the development of antibodies for therapeutic, diagnostics, and research applications.It operates through the following segments: Partnered Discovery, Proprietary Development and AbD Serotec.The Partnered Discovery segment involves technologies for the generation of human... 
More about the company
Surperformance© ratings of MorphoSys AG
Trading Rating : Investor Rating :
More Ratings
Latest news on MORPHOSYS AG
06/20 MORPHOSYS : Reports Publication of Clinical Case Report of a Blood Cancer (DLBCL..
06/17 MORPHOSYS : Reports Publication of Clinical Case Report of a Blood Cancer (DLBCL..
06/14 MORPHOSYS AG : Publication pursuant to §26 sect.1 WpHG (the German Securities Tr..
06/07 MORPHOSYS : Genedata Expands Partnership with MorphoSys to Support New Antibody ..
06/06 MORPHOSYS : Presents Updated Clinical Data for MOR202 in Multiple Myeloma and fo..
06/03 MORPHOSYS AG : Publication pursuant to §26 sect.1 WpHG (the German Securities Tr..
06/02 MORPHOSYS : AG Reports Outcome of Annual General Meeting 2016
06/01 MORPHOSYS : to Present at Six Upcoming Conferences
05/24 MORPHOSYS : and MD Anderson Cancer Center Join Forces for the Development of Nov..
05/24 MORPHOSYS : and MD Anderson Cancer Center Join Forces for the Development of Nov..
More news
Sector news : Biotechnology & Medical Research - NEC
06/25 NOVARTIS : SC requests solicitor general to consider on biosimilars
06/24DJMedpace Files for IPO
06/24DJMEDIVATION : Glass Lewis Backs Medivation Board in Sanofi Dispute
06/24 MEDIVATION : Glass Lewis Recommends Medivation's Stockholders Support the Compan..
06/24 MEDIVATION : Glass Lewis Recommends Medivation’s Stockholders Support the ..
More sector news : Biotechnology & Medical Research - NEC
News from SeekingAlpha
05/03 MorphoSys' (MPSYF) CEO Simon Moroney on Q1 2016 Results - Earnings Call Trans..
05/03 MorphoSys AG reports Q1 results
03/11 Upcoming Events - Pivotal Data For Novartis And Perhaps Aduro Too
03/02 MorphoSys' (MPSYF) CEO Simon Moroney on Q4 2015 Results - Earnings Call Trans..
03/02 MorphoSys AG reports Q4 results
Advertisement
Chart MORPHOSYS AG
Duration : Period :
MorphoSys AG Technical Analysis Chart | MOR | DE0006632003 | 4-Traders
Full-screen chart
Technical analysis trends MORPHOSYS AG
Short TermMid-TermLong Term
TrendsBearishNeutralBearish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions